# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.capitoltrades.com/trades/20003774100
- SEC Filing
Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of ...